State Street Corporation has appointed healthcare product producer Covidien chairman José (Joe) E. Almeida to its board of directors.
With more than 18 years leadership experience at the large public company, Almeida will bring a valuable knowledge of innovation and competition to the financial services research group, Joseph L. Hooley, chairman, president and chief executive officer of State Street Corporation, said.
Almeida joined Covidien in 1995 and has served as chairman of the company's board of directors since March 2012.
He has also previously held senior roles at Greatbatch Technologies, Inc., American Home Products' Acufex Microsurgical division and Johnson & Johnson's professional products division.
Almeida is also on the board of directors at Advanced Medical Technology Association (AdvaMed) and Partners in Health.
Cbus has swiftly promoted Leigh Gavin to chief investment officer only months after naming him deputy, as the fund works towards growing in size and bringing its investment expertise in-house.
Bravura CEO Andrew Russell has announced he will be stepping down from the company, just under two years after his appointment.
The $16 billion fund has teamed up with a retirement income product specialist to give its members more confidence to spend in retirement.
The super fund-owned institutional investment manager has appointed an internal candidate as its next head of operations.